Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1978 2
1980 1
1982 1
1984 1
1987 1
1988 1
1990 1
1992 1
1993 1
1996 3
2000 2
2003 1
2004 2
2005 3
2006 4
2007 2
2008 7
2009 9
2010 7
2011 5
2012 2
2013 5
2014 4
2015 5
2016 2
2017 4
2018 13
2019 12
2020 15
2021 7
2022 6
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Early Pulmonary Rehabilitation in COVID-19 Disease.
Schindler I, Kolditz M, Seidel A, Tausche K, Vogler M, Koschel D. Schindler I, et al. Among authors: vogler m. Dtsch Arztebl Int. 2022 Apr 8;119(14):261-262. doi: 10.3238/arztebl.m2022.0130. Dtsch Arztebl Int. 2022. PMID: 35794803 Free PMC article. No abstract available.
Unleashing the power of NK cells in anticancer immunotherapy.
Vogler M, Shanmugalingam S, Särchen V, Reindl LM, Grèze V, Buchinger L, Kühn M, Ullrich E. Vogler M, et al. J Mol Med (Berl). 2022 Mar;100(3):337-349. doi: 10.1007/s00109-021-02120-z. Epub 2021 Aug 9. J Mol Med (Berl). 2022. PMID: 34374809 Free PMC article. Review.
It's time to die: BH3 mimetics in solid tumors.
Kehr S, Vogler M. Kehr S, et al. Among authors: vogler m. Biochim Biophys Acta Mol Cell Res. 2021 Apr;1868(5):118987. doi: 10.1016/j.bbamcr.2021.118987. Epub 2021 Feb 15. Biochim Biophys Acta Mol Cell Res. 2021. PMID: 33600840 Free article. Review.
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy.
Ullrich E, Vogler M, von Metzler I. Ullrich E, et al. Among authors: vogler m. Signal Transduct Target Ther. 2022 Aug 18;7(1):291. doi: 10.1038/s41392-022-01126-4. Signal Transduct Target Ther. 2022. PMID: 35982042 Free PMC article. No abstract available.
Resistance to HIV infection.
Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M. Marmor M, et al. Among authors: vogler m. J Urban Health. 2006 Jan;83(1):5-17. doi: 10.1007/s11524-005-9003-8. J Urban Health. 2006. PMID: 16736351 Free PMC article. Review.
Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma.
Jacob M, Wiedemann S, Brücher D, Pieper NM, Birkhold M, Särchen V, Jeroch J, Demes MC, Gretser S, Braun Y, Gradhand E, Rothweiler F, Michaelis M, Cinatl J Jr, Vogler M. Jacob M, et al. Among authors: vogler m. Br J Cancer. 2023 Nov;129(10):1667-1678. doi: 10.1038/s41416-023-02430-8. Epub 2023 Sep 19. Br J Cancer. 2023. PMID: 37723317 Free PMC article.
125 results